Gleevec 400 mg/1

Gleevec 400 mg tablets are a prescription medication used to treat certain types of cancer. This oral medication is manufactured by Novartis Pharmaceuticals Corporation in the USA.

Gleevec 400 mg tablets are primarily used in the treatment of specific types of cancer. The active ingredient, imatinib mesylate, works by targeting certain proteins involved in cancer cell growth. This medication is often prescribed for conditions like chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Patients should consult their healthcare provider to understand what Gleevec is used for in their specific case.

Common effects of Gleevec 400 mg tablets may include nausea, diarrhea, muscle cramps, and swelling. Some users might experience fatigue or skin rashes. These effects can vary from person to person, and not everyone will experience them. It's important to discuss any concerns with a healthcare professional.

Gleevec 400 mg tablets should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should inform their doctor about any other medications they are taking to avoid potential interactions. Pregnant or breastfeeding women should consult their healthcare provider before using this medication.

Gleevec 400 mg tablets may interact with certain medications, including those that affect liver enzymes. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or side effects of the medication.